Clinical Trial Update: Artesunate Ointment for the Treatment of High Grade Vulvar Intraepithelial Neoplasia (HSIL VIN2/3) [Phase 1]

View source ↗

Summary

A Phase 1 trial of Artesunate ointment for high-grade vulvar intraepithelial neoplasia (VIN2/3) has completed; no efficacy results are provided in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvar Dysplasia
• Vulvar Intraepithelial Neoplasia

Drugs mentioned

• Artesunate ointment (Artesunate)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Vulvar Dysplasia, HPV-Related Vulvar Intraepithelial Neoplasia | Phase 1 | Status: COMPLETED